JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on January 30, 2004
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
279/5/3202    most recent
M310010200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Faisal, A.
Right arrow Articles by Nagamine, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faisal, A.
Right arrow Articles by Nagamine, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print October 23, 2003
J. Biol. Chem, 10.1074/jbc.M310010200
Submitted on September 9, 2003
Revised on October 13, 2003
Accepted on October 23, 2003

Non-redundant role of ShcA in Erk activation by cytoskeletal reorganization

Amir Faisal, Sandra Kleiner, and Yoshikuni Nagamine

Friedrich Miescher Institute, Basel, BS CH-4058

Corresponding Author: nagamine{at}fmi.ch

We have shown previously that cytoskeletal reorganization (CSR) induced by pharmacological reagents such as colchicine or cytochalasins can upregulate the urokinase-type plasminogen activator (uPA) gene via the Ras/Erk signaling pathway. In this present study using the siRNA technique, we have found that ShcA adapter proteins play a rather active role in CSR-induced Erk activation, contrary to their mostly redundant role in other signaling pathways, e.g. growth factor-induced Erk activation, where Grb2 can bind directly to the receptor tyrosine kinase and activate Erk in the absence of ShcA. ShcA knockdown abolished CSR-induced activation of both Erk and the uPA promoter. Expression of siRNA-escaping silent mutants of p52 or p46 but not p66 ShcA isoform efficiently rescued CSR-induced Erk activation. Moreover, we have shown that phosphorylation of either Y239/240 or Y313 in p52ShcA can mediate CSR-induced Erk activation equally well. In a quest for molecules upstream of ShcA in this signaling, we found that CSR-induced ShcA tyrosine phosphorylation, its association with Grb2, Erk activation and uPA gene expression were all dependent on Rho kinase, p38 MAP kinase and Src. In summary, we have found a novel, non-redundant role for ShcA, in contrast to its redundant role in many other signaling pathways.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
I. Arany, A. Faisal, Y. Nagamine, and R. L. Safirstein
p66shc Inhibits Pro-survival Epidermal Growth Factor Receptor/ERK Signaling during Severe Oxidative Stress in Mouse Renal Proximal Tubule Cells
J. Biol. Chem., March 7, 2008; 283(10): 6110 - 6117.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
M. Honma, O. Higuchi, M. Shirakata, T. Yasuda, H. Shibuya, S.-i. Iemura, T. Natsume, and Y. Yamanashi
Dok-3 sequesters Grb2 and inhibits the Ras-Erk pathway downstream of protein-tyrosine kinases
Genes Cells, February 1, 2006; 11(2): 143 - 151.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Qian, K. J. Liu, Y. Chen, D. C. Flynn, V. Castranova, and X. Shi
Cdc42 Regulates Arsenic-induced NADPH Oxidase Activation and Cell Migration through Actin Filament Reorganization
J. Biol. Chem., February 4, 2005; 280(5): 3875 - 3884.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Venugopal, K. Hanashiro, Z.-Z. Yang, and Y. Nagamine
Identification and modulation of a caveolae-dependent signal pathway that regulates plasminogen activator inhibitor-1 in insulin-resistant adipocytes
PNAS, December 7, 2004; 101(49): 17120 - 17125.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.